← Back to GOSS

Gossamer Bio, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 05/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Sep 2024Filed 05/11/2025Jun 2024Filed 05/11/2025Mar 2024Filed 05/11/2025
$9.2$17$13$11$9.9$9.5$96$0
$17−$47−$48−$38−$37−$31$49−$42
−$0.08−$0.20−$0.21−$0.17−$0.16−$0.14$0.22−$0.19
329234228227227226239226

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.